Cart
sales@molnova.com
Monolaurin
CAS No. 142-18-7
Monolaurin( —— )
Catalog No. M21137 CAS No. 142-18-7
Monolaurin is a surfactant and emulsifer found in coconut oil. It inhibitis growth of Staphylococcus Streptococcus Gardnerella Candida and Haemophilus and decreases production of pro-inflammatory cytokines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 38 | Get Quote |
|
| 200MG | 58 | Get Quote |
|
| 500MG | 104 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMonolaurin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMonolaurin is a surfactant and emulsifer found in coconut oil. It inhibitis growth of Staphylococcus Streptococcus Gardnerella Candida and Haemophilus and decreases production of pro-inflammatory cytokines.
-
DescriptionMonolaurin is a surfactant and emulsifer found in coconut oil. It inhibitis growth of Staphylococcus Streptococcus Gardnerella Candida and Haemophilus and decreases production of pro-inflammatory cytokines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142-18-7
-
Formula Weight274.4
-
Molecular FormulaC15H30O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (45.55 mM)
-
SMILESCCCCCCCCCCCC(=O)OCC(O)CO
-
Chemical Name23-dihydroxypropyl dodecanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.NORBERTO LISKER NACHMAN et al. ANTIFUNGAL ACTIVITY OF MONOLAURIN AND RELATED COMPOUNDS[J]. Journal of Food Safety 1982.
molnova catalog
related products
-
3-Morpholino-1-(4-(2...
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one shows antitumor activity in a human colon cancer cell line and may be used to combat thrombosis.
-
AI-10-47
AI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).
-
Zolbetuximab
Zolbetuximab(IMAB362) is a monoclonal antibody that specifically targets Claudin-18.2.Zolbetuximab has potential antitumor activity, mediating killing of Claudin-18.2-positive cells through an immune effector mechanism.
